Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL

Summary

Researchers are trying to find out more about the side effects of fremanezumab when treating patients with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) for migraine headaches.

Timeline

Start

2021-12

Primary completion

2024-12

Completion

2024-12

Outcome

Outcome not reported

Stopped (Business): “Lack of funding to support the trial.”

Drugs

Indications